June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Karen Knudsen: VOICES of Black Women will allow us to uncover the unique challenges that lead to cancer disparities
May 10, 2024, 13:58

Karen Knudsen: VOICES of Black Women will allow us to uncover the unique challenges that lead to cancer disparities

Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding:

“Designed to further our understanding and improve the health of Black women nationwide, VOICES will allow us to uncover the unique challenges that lead to cancer disparities.

I am proud of the American Cancer Society for leading such a monumental, important population study and encourage everyone to get more information at voices.cancer.org

Quoting American Cancer Society’s post:

“Today the American Cancer Society announced VOICES of Black Women – a bold step in our mission to end cancer as we know it, for everyone. VOICES isn’t just a study; it’s a collective commitment to understanding and improving the health of Black women across the nation. Your voice today can change our collective future forever. Get more information at voices.cancer.org. Full announcement.”

Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States.
OncoDaily
She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.